AVEO

Related by string. Aveo * * Chevrolet Aveo subcompact . specificity AVEO believes . Chevrolet Aveo . Chevy Aveo . AVEO Pharmaceuticals Inc. . AVEO Pharmaceuticals . Aveo U . Aveo Pharmaceuticals . AVEO proprietary . Chevrolet Aveo U . AVEO Pharmaceuticals NASDAQ . Aveo RS show . NASDAQ AVEO biopharmaceutical . Aveo sedan . Aveos Fleet Performance . Chevrolet Aveo RS . Aveo RS *

Related by context. All words. (Click for frequent words.) 64 CombinatoRx 64 Opexa 63 Idenix 63 tivozanib 62 Micromet 62 Enzon 61 Anacor 61 Celldex 61 Ligand 61 FoldRx 60 ImmunoGen 60 Archemix 60 ExonHit 60 Tolerx 59 preclinical 59 Tranzyme 59 Incyte 59 Synta 59 Ceregene 59 Zalicus 59 Proteolix 59 Sunesis 59 Plexxikon 59 SuperGen 59 Exelixis 59 NovaBay 59 Clavis Pharma 58 Anthera 58 AVEO Pharmaceuticals 58 OXiGENE 58 therapeutic antibody 58 Dyax 58 VentiRx 58 Neurogen 58 Trubion 58 CorMedix 58 Corcept 58 ArQule 57 Curis 57 Cylene 57 Lpath 57 Immunogen 57 Genitope Corporation 57 Molecular Insight 57 XOMA 57 Anaphore 57 Metabasis 57 Mpex 57 Ardea Biosciences 57 OncoVEX 57 SEQUENOM 57 Omeros 56 PsychoGenics 56 Seattle Genetics 56 Harbor BioSciences 56 Regeneron 56 Allovectin 7 56 Vaccinex 56 Idera Pharmaceuticals 56 Mersana 56 3SBio 56 Arqule 56 Clinical Data 56 Dicerna 56 Symphogen 56 ACLARA 56 OncoMed 56 Ziopharm 56 Hana Biosciences 56 AVEO Pharmaceuticals Inc. 56 ALN VSP 56 Intellikine 56 Taligen 56 Vion Pharmaceuticals 56 IDM Pharma 56 Sunesis Pharmaceuticals 56 JAK3 56 Peregrine Pharmaceuticals 56 Medarex 56 Kosan 56 OGeS 56 Medivation 56 Adherex 56 InNexus 56 Aegera 55 MacroGenics 55 Rexahn Pharmaceuticals 55 Alfacell 55 RXi 55 BiTE antibody 55 therapeutic monoclonal antibodies 55 Inovio 55 Metabasis Therapeutics Inc. 55 Oncolin 55 Idenix Pharmaceuticals 55 Celator 55 AspenBio 55 ZymoGenetics 55 Scancell 55 Xencor 55 Chemokine Therapeutics 55 Chemokine 55 NASDAQ AVEO 55 ACADIA 55 AEterna Zentaris 55 OncoGenex 55 PXD# 55 Epitomics 55 IMC #B 55 Genetronics 55 ADVENTRX 55 TorreyPines 55 Azedra TM 55 Syndax 55 ChemoCentryx 55 Semafore 55 TRACON Pharmaceuticals 55 ARIUS 55 Ibis Biosciences 55 QuatRx 55 Evotec 55 Response Genetics 55 Coley Pharmaceutical Group 55 ESBATech 55 Merrimack Pharmaceuticals 55 AVANIR 55 Hybridon 55 Achillion 55 BioSeek 55 XmAb# 55 InSite Vision 55 Affitech 54 Jennerex 54 BioInvent 54 Protox 54 Gemin X 54 BioMS Medical 54 Galenea 54 Cempra 54 Algeta 54 Sym# 54 Innovive 54 Syntonix 54 BioMS 54 Poniard 54 Abgenix 54 Oxxon 54 BioMarin 54 Affymax 54 CEQ# 54 AcelRx 54 IAP inhibitors 54 HuMax CD# 54 ChemGenex 54 Nanobody 54 Novexel 54 Altus Pharmaceuticals 54 KineMed 54 Cerimon 54 Daclizumab 54 ChemGenex Pharmaceuticals Limited 54 daclizumab 54 Dynogen 54 OXi# 54 immatics 54 Excaliard 54 Novelos 54 proprietary phage display 54 therapeutic antibodies 54 Arresto 54 Cytopia 54 Neose 54 Aveo Pharmaceuticals 54 Juvaris 54 ARIAD 54 VisEn Medical 54 Dynavax 54 Guanilib 54 Ambrx 54 TapImmune 54 XL# [003] 54 monoclonal antibodies 54 GPC Biotech 54 Targacept 54 Myocet 54 VistaGen 54 Sopherion 54 Nasdaq MBRX announced 54 HepaLife 54 Targanta 54 Epimmune 54 MultiCell 54 phase IIb clinical 54 Innovive Pharmaceuticals 54 CGEN # 54 Phenomix 53 Igeneon 53 XL# XL# 53 Pharmasset 53 Receptos 53 Avila Therapeutics 53 bardoxolone 53 CYT# potent vascular disrupting 53 Phase Ib 53 dacetuzumab 53 Threshold Pharmaceuticals 53 TorreyPines Therapeutics 53 Jerini 53 Ablynx 53 elesclomol 53 Maxygen 53 Amorfix 53 MorphoSys 53 Nuvelo 53 Diatos 53 drug conjugate 53 Ciphergen 53 Tengion 53 Cellgate 53 Novelos Therapeutics 53 MAbs 53 MEK inhibitor 53 TESARO 53 Corautus 53 Alnylam 53 immunotherapeutics 53 CytRx 53 Alimera 53 Synta Pharmaceuticals 53 drug conjugate ADC 53 CoMentis 53 Anticalin R 53 Cell Genesys 53 Bionovo 53 Transgene 53 obatoclax 53 Daniel Junius 53 Myrexis 53 cancer immunotherapies 53 Viventia 53 Kolltan Pharmaceuticals 53 Lorus 53 PEG SN# 53 TetraLogic 53 Sirtris 53 Factor VIIa 53 PDE4 inhibitor 53 Panacos 53 BioFocus 53 Calistoga Pharmaceuticals 53 MediciNova 53 Inotek 53 IMA# 53 Annamycin 53 Nanobody ® 53 LEAD Therapeutics 53 HGS ETR1 53 Adenosine Therapeutics 53 PLX# 53 Pervasis 53 novel antibody therapeutics 53 ParAllele 53 Athersys 53 Keryx Biopharmaceuticals 53 Replidyne 53 Bicifadine 53 ViroLogic 53 MT# MEDI 53 Rexahn 53 antisense inhibitors 53 ganetespib 53 MAb 53 Genaissance 53 ZIOPHARM 53 Neurimmune 53 Æterna Zentaris 53 Avicena 53 HGS# 53 Tarvacin TM 53 Graffinity 53 Advanced Magnetics 53 Resolvyx 53 MGI PHARMA 53 ABII 53 Transgenomic 53 preclinical studies 53 Prednisporin 52 Poniard Pharmaceuticals 52 Cytogen 52 PORxin TM 52 Threshold Pharmaceuticals Inc. 52 FORMA Therapeutics 52 EntreMed 52 vascular disrupting agents 52 EyeGate Pharma 52 Provectus Pharmaceuticals 52 HCV protease inhibitor 52 Intarcia 52 Furiex 52 Facet Biotech 52 ImmunoCellular 52 ProSavin 52 TolerRx 52 AP# [003] 52 sapacitabine 52 AEZS 52 elotuzumab 52 DOS# 52 Stemgent 52 KAI Pharmaceuticals 52 SGX Pharmaceuticals 52 Xcyte 52 AVN# [001] 52 MyVax R 52 Transcept 52 VitiGam 52 Aspreva 52 GenVec 52 Karo Bio 52 Salmedix 52 Neuraltus 52 Adventrx 52 KYTHERA 52 FOLOTYN ® 52 MDV# 52 ALN PCS 52 Suven 52 SYGNIS 52 Infinity Pharmaceuticals 52 Can Fite 52 EnVivo 52 LymphoStat B TM 52 Regulus Therapeutics 52 Ocrelizumab 52 Angiocept 52 Caprion 52 JAK1 52 VEGF Trap 52 zanolimumab 52 ACHN 52 NanoViricides 52 Anadys 52 Aegerion 52 Ophthotech 52 Archexin 52 betrixaban 52 GED aPC 52 ExonHit Therapeutics 52 MacroChem 52 Synageva 52 Tragara Pharmaceuticals Inc. 52 DPX Survivac 52 Mesoblast 52 HuMax CD4 52 Inpharmatica 52 Inhibitex 52 therapeutics 52 Neurologix 52 NASDAQ SGEN 52 NASDAQ ABII 52 Relypsa 52 EvoGenix 52 Symadex 52 CB2 selective 52 Neurocrine 52 Epizyme 52 GRN# 52 AnaptysBio 52 Isis Pharmaceuticals ISIS 52 CCX# 52 JAK inhibitor 52 oncology therapeutics 52 INCB# [001] 52 Genelabs 52 Acetylon 52 ProLindac 52 ImmunoGen Inc. 52 NASDAQ LGND 52 Sirona Biochem 52 kinase inhibitors 52 Alnara 52 Auxilium Pharmaceuticals 52 entinostat 52 cancer therapeutics 52 BioSante 52 Proxinium TM 52 Nasdaq VRTX 52 Bayer Schering Pharma 52 isoform selective 52 Phase 1b trial 52 TOCOSOL Paclitaxel 52 BioDelivery Sciences 52 XenoPort 52 Phase Ib study 52 Aileron Therapeutics 52 OMP #M# 52 DAVANAT 52 targeting CD# 52 Pharmion Corporation 52 MOZOBIL 52 ANG# 52 NOXXON 52 AVRX 52 bluebird bio 52 Versartis 52 PRAECIS 52 Emisphere Technologies 52 Ardea 52 Aastrom 51 MIGENIX 51 TargeGen 51 UltiMAb ® 51 Calando 51 Oscient 51 Addex 51 OvaRex R 51 Regeneron Pharma 51 outlicensing 51 tranilast 51 Dr. Marlies Sproll 51 Regeneron Pharmaceuticals 51 Sucampo Pharmaceuticals 51 AMEX INO 51 Jean Pierre Sommadossi Ph.D. 51 iCo 51 PDE# inhibitors 51 Helix BioMedix 51 TOPIGEN 51 NovaDel 51 BioTime 51 CoGenesys 51 Durect 51 Cellzome 51 biologic therapies 51 BioWa 51 BioCurex 51 OncoSec 51 BioFocus DPI 51 pradefovir 51 Scil Proteins 51 targeted radiotherapeutic 51 RGDX 51 RAV# 51 CeNeS 51 VASTox 51 carfilzomib 51 Chimigen TM 51 phase IIa clinical 51 Alnara Pharmaceuticals 51 Verisante 51 PLK1 SNALP 51 dermatology therapies 51 HCD# [002] 51 Halozyme 51 ibudilast 51 Abraxis BioScience 51 ENMD # 51 Astex 51 MEK inhibitors 51 Curaxin 51 Biogen Idec NASDAQ BIIB 51 Spectrum Pharmaceuticals 51 Taligen Therapeutics 51 Royalty Pharma 51 NeurogesX 51 Cytokinetics 51 ENMD 51 Aerovance 51 Biotie 51 telomerase therapeutic 51 Kyowa Hakko Kirin 51 NASDAQ OPXA 51 Theravance 51 arGEN X 51 FermaVir 51 HistoRx 51 eniluracil 51 AKIP ™ 51 MabCure 51 ridaforolimus 51 BRAF inhibitor 51 Phase #b/#a clinical 51 Xenogen 51 BiTE 51 Pharmion 51 Fibrocell Science 51 Abraxis 51 aTyr Pharma 51 Cyclacel Pharmaceuticals 51 Adeona 51 Nasdaq IVGN 51 Panzem 51 Helix BioMedix Inc. 51 Lycera 51 AQ4N 51 ALN TTR 51 Telik 51 AEG# 51 Memryte 51 Nasdaq ISIS 51 Addrenex 51 Elixir Pharmaceuticals 51 PRNewswire FirstCall Pharmasset 51 OncoGenex Pharmaceuticals Inc. 51 Nasdaq RDEA 51 Syrrx 51 Montigen 51 OncoVEX GM CSF 51 PSMA ADC 51 Neurobiological Technologies 51 BioVex 51 novel peptides 51 ATHX 51 NASDAQ ISIS 51 BiPar 51 Lipid Sciences 51 Acologix 51 Ridaforolimus 51 Oasmia 51 Innate Pharma 51 Corgentech 51 Anticalin 51 oncology 51 AEterna 51 Amarantus 51 Vegenics 51 PDL# 51 RNAi therapeutic 51 HspE7 51 Speedel 51 DXL# 51 Incara 51 Ore Pharmaceuticals 51 Inflazyme 51 Enanta 51 Palatin Technologies 51 Orexo 51 ViroChem Pharma Inc. 51 FluoroPharma 51 tubulin inhibitor 51 JAK2 inhibitor 51 PRX # 51 metaglidasen 51 Nanobody R 51 ImmuPharma 51 pan HDAC inhibitor 51 Array BioPharma 51 NTII 51 HuLuc# 51 Acadia Pharmaceuticals 51 Gene Logic 51 Cequent Pharmaceuticals 51 Tobira Therapeutics 51 Ventrus 51 SIMPLE Antibody TM 51 ErbB3 51 seliciclib CYC# 51 ANAVEX 51 Seattle Genetics SGEN 51 ARRY 51 Metabolex 51 PanGenetics 51 FoldRx Pharmaceuticals Inc. 51 EGEN 51 CoTherix 51 FivePrime 51 nicotinic alpha 7 51 UltiMAb 51 PAION 51 Arpida 51 tanespimycin 51 Immunotherapeutic 51 Phase IIa trials 51 Memory Pharmaceuticals 51 Portola Pharmaceuticals 51 GlycArt 51 bavituximab 51 Icagen 51 PEG Interferon lambda 51 Apthera 50 Provectus Pharmaceuticals specializes 50 Raptor Pharmaceutical 50 Synavive 50 GTx 50 exon skipping 50 oral ridaforolimus 50 EnVivo Pharmaceuticals 50 Targeted Chemotherapy 50 epothilone 50 IMGN 50 Personalized Immunotherapy 50 Hematide ™ 50 Astellas 50 Alantos 50 SciClone Pharmaceuticals Inc. 50 Bioject 50 Bioenvision 50 Immunovaccine 50 CR# vcMMAE 50 Progenics Pharmaceuticals 50 ARYx 50 Sphingomab 50 MT#/MEDI-# 50 Cardioxyl 50 mAb 50 TopoTarget 50 ThromboGenics 50 ArQule Kinase Inhibitor Platform 50 Biovitrum 50 Howard H. Pien 50 Apexigen 50 Ardea Biosciences Inc. 50 CRXX 50 Alnylam Pharmaceuticals 50 Affimed 50 oral Azacitidine 50 PDL BioPharma 50 MOGN 50 MLN# 50 Achaogen 50 Diasome 50 Phase 2b trial 50 CA4P 50 enzastaurin 50 Nasdaq HALO 50 RXi Pharmaceuticals 50 Genentech Roche 50 4SC AG 50 PRT# 50 novel RNAi therapeutics 50 CombinatoRx Incorporated NASDAQ CRXX 50 Helicon Therapeutics 50 AKIP 50 OPKO 50 immunological diseases 50 Genome Therapeutics 50 Hoyoung Huh 50 CoNCERT 50 X Ceptor 50 Cardioxyl Pharmaceuticals 50 Mitchel Sayare 50 Pharmexa 50 Adnexus 50 epothilones 50 ARQL 50 Nasdaq RXII 50 HepeX B 50 Oxigene 50 selective androgen receptor modulator 50 Trofex 50 Compugen NASDAQ CGEN 50 Serenex 50 Xenoport Inc. 50 CLDA 50 NASDAQ ALNY 50 Clinipace 50 molecular diagnostic 50 Auxilium Pharma 50 HCV protease inhibitors 50 ADVENTRX Pharmaceuticals 50 GENR 50 Nasdaq ENZN 50 Biolex 50 CancerGuide 50 Ascent Therapeutics 50 Virulizin 50 DiscoveRx 50 alvespimycin 50 Synvista Therapeutics 50 Cellegy 50 Inc. AMEX YMI 50 PI3K inhibitor 50 Tod Woolf Ph.D. 50 NovaCardia 50 Intrexon 50 Stapled Peptide 50 Oncolys 50 VIRxSYS 50 Antisense 50 NeuroMedix 50 biomarker discovery 50 NASDAQ INGN 50 Myriad Pharmaceuticals 50 SAR# [002] 50 INGN 50 SangStat 50 Metabasis Therapeutics 50 Critical Therapeutics 50 Pharnext 50 molecular imaging radiopharmaceutical 50 therapeutic monoclonal antibody 50 Geron 50 GenPath 50 AFFiRiS 50 Santhera 50 Litx 50 Antisoma 50 Solazed TM 50 MacroPore Biosurgery 50 MultiCell Technologies 50 Mipomersen 50 Santaris Pharma 50 Regado 50 Solazed 50 ALN TTR# 50 JAK inhibitors 50 Atiprimod 50 Enzon Pharmaceuticals Inc. 50 Virulizin ® 50 glucokinase activator 50 Isotechnika 50 Hsp# inhibitor 50 teplizumab 50 Active Biotech 50 LEX System 50 NASDAQ OGXI 50 cancer immunotherapy 50 EpiCept 50 MEK inhibitor RDEA# 50 WILEX 50 huC# DM4 50 RayBiotech 50 Nasdaq XOMA 50 anticancer therapies 50 Kyto 50 Cytori Therapeutics NASDAQ CYTX 50 NPS Pharmaceuticals 50 Chromos 50 Eyetech Pharmaceuticals Inc. 50 immunoregulation 50 Somaxon 50 Quinamed 50 Trubion Pharmaceuticals 50 Oncothyreon 50 EnzymeRx 50 ImmunoCellular Therapeutics 50 BioRexis 50 ChemDiv 50 Rigel Pharmaceuticals Inc. 50 Ampio 50 Domantis 50 antisense drug 50 GlycoMimetics 50 initiated Phase 1b 50 deforolimus 50 Celgene 50 Cardiome 50 REGiMMUNE 50 Dicer Substrate Technology 50 Aegera Therapeutics 50 rNAPc2 50 preclinically 50 Aeolus Pharmaceuticals 50 PRNewswire FirstCall YM BioSciences 50 Trubion Pharma 50 Mr. Bentsur 50 Perlegen 50 Albugon 50 LungExpress Dx 50 Neuro Hitech 50 HQK 50 Dynavax Technologies Corporation 50 omacetaxine 50 Gen Probe 50 Agios Pharmaceuticals 50 VisEn 50 Ceflatonin R 50 Provectus 50 Tekmira 50 XmAb ™ 50 NKTR 50 CCR9 antagonist 50 Opexa Therapeutics Inc. 50 LungExpress Dx TM 50 SciClone 50 Santaris 50 Dyax phage display 50 CD# antibody [001] 50 Applied NeuroSolutions 50 Nasdaq NPSP 50 Palatin 50 Cephalon NASDAQ CEPH 50 SUCCEED trial 50 Molecular Templates 50 Alnylam Pharma 50 antibody therapeutics 50 Azedra 50 ENZN 50 monoclonal antibody 50 DiaKine 50 lintuzumab 50 Viamet 50 Hedgehog antagonist 50 CRLX# 50 ALTU 50 InterMune 50 orally bioavailable 50 Avalon Pharmaceuticals 50 Embryome Sciences 50 IgG1 antibody 50 SGMO 50 AMEX RGN 50 HepDirect 50 Onalta 50 Euroscreen 50 Onconova 50 GNLB 50 Axonyx 50 Ariad 50 Avanir 50 AlphaRx 50 NovImmune 50 CollaGenex 50 Response Genetics Inc. 50 midstage clinical 50 Carfilzomib 50 Peregrine Pharmaceuticals Inc. 50 Novacea 50 vascular disrupting agent 50 Phase IIa clinical trials 50 Hsp# inhibition 50 Novavax 50 Kiadis Pharma 50 PARP inhibitor 50 mitogen activated ERK kinase 50 lixivaptan 50 Inc. Nasdaq INFI 50 sirtuin therapeutics 50 Protalix 50 StemCells 50 Syncria 50 CytoFab 50 Vincent Mutel CEO 50 ALD# 50 Inovio Biomedical 50 Proximagen 50 Lux Biosciences 50 Keryx 50 Resverlogix 50 Neoprobe 50 Hollis Eden 49 NBIX 49 Harry Palmin President 49 AclarusDx ™ 49 Inc. NASDAQ SGEN 49 danoprevir 49 Gastrotech 49 stem cell therapeutics 49 Illumigen 49 Nasdaq ACHN 49 Tularik 49 ALNY 49 Fresenius Biotech 49 miRNA therapeutics 49 Adnexus Therapeutics 49 Phase Ib clinical 49 Nuevolution 49 telomerase inhibitor drug 49 Zosano 49 Nanobodies 49 AVANT 49 SuperAntibody 49 Zemiva TM 49 small molecule 49 preclinical toxicology 49 VLST 49 Compugen 49 Genaera 49 Cytochroma 49 vivo validation 49 Matritech 49 Omthera 49 PI3K delta 49 lumiliximab 49 midstage studies 49 Harvard Bioscience 49 NeuroSearch 49 otelixizumab 49 Debio 49 Enanta Pharmaceuticals 49 personalized immunotherapy 49 Cytori NASDAQ CYTX 49 Genstruct 49 Xanafide 49 Nasdaq ARRY 49 PRNewswire FirstCall Isis Pharmaceuticals 49 Traficet EN 49 Nasdaq IDRA today 49 Numoda 49 Onalta TM 49 Sangamo BioSciences 49 Anticalin ® 49 EndoTAG 49 PhaseBio 49 SARcode 49 Ascenta Therapeutics 49 oncolytic virus 49 ApoB SNALP 49 IMC A# 49 Sernova 49 ThermoDox R 49 R#/MEM # 49 siRNA delivery 49 Innodia 49 Elusys 49 Encorium 49 XOMA XOMA 49 Nasdaq INCY 49 ISIS # 49 Axordia 49 OTCBB UGNE http:/www.unigene.com 49 Omeros Corporation 49 monoclonal antibody mAb 49 KemPharm 49 Tarvacin 49 Chemgenex 49 CombinatoRx Incorporated 49 molecular chaperone 49 Quark Pharmaceuticals 49 NASDAQ THLD 49 Allovectin 7 R 49 Oxford BioMedica 49 Alseres 49 PHX# 49 ImaRx 49 Nasdaq ACAD 49 EndoTAG TM -1 49 Alexis Borisy President 49 Rexahn Pharmaceuticals Inc. 49 TRO# 49 Prodarsan ® 49 Xenomics 49 Spiro Rombotis President 49 AEGR 49 investigational pan BCR 49 Exelixis compounds 49 Bellicum 49 Nexavar sorafenib 49 NASDAQ PRCS 49 preclinical efficacy 49 SCOLR Pharma 49 Robert L. Bratzler 49 NYSE Amex PTN 49 Exelixis EXEL 49 Reata Pharmaceuticals 49 NASDAQ GERN 49 Conatus Pharmaceuticals 49 Genmab 49 Trofex TM 49 Nasdaq PARD biopharmaceutical 49 Trubion Pharmaceuticals TRBN 49 GRN#L 49 RegeneRx 49 Opko 49 Allos 49 Troxatyl 49 NanoString 49 Eyetech 49 virus HCV protease inhibitor 49 ocrelizumab 49 CardioVascular BioTherapeutics Inc. 49 GPR# agonist 49 novel anti infective 49 Acasti 49 Stapled Peptides 49 EntreMed Inc. 49 Tranzyme Pharma 49 MGCD# [001] 49 HuMax TAC 49 Advanced BioHealing 49 functional genomics 49 SARMs 49 Quark Biotech 49 Atugen 49 NeoGenomics 49 Apitope 49 Virulizin R 49 Inimex 49 XmAb ® 49 Urigen 49 MGI Pharma 49 PROfusion 49 Immunicon 49 selective kinase inhibitor 49 T DM1 49 BioCryst 49 Cardium Therapeutics 49 Calixa 49 Amsterdam Molecular Therapeutics 49 SGXP 49 nonclinical studies 49 EP #R 49 ProMune 49 GSK # 49 ImClone Systems Incorporated 49 LymphoStat B 49 Xanthus Pharmaceuticals Inc. 49 Tercica 49 Isis Pharmaceuticals

Back to home page